Blinklab (ASX:BB1) is gearing up for FDA approval and commercial rollout
Blinklab (ASX:BB1) We spoke to Henk-Jan Boele, CEO of Blinklab (ASX:BB1), about the company’s roadmap to…
St George Mining (ASX:SGQ) is grabbing a major niobium opportunity in Brazil
St George Mining (ASX:SGQ) We spoke to John Prineas, Executive Chair of St George Mining (ASX:SGQ),…
Weebit Nano (ASX:WBT) signs its biggest customer yet: Interview with CEO
Weebit Nano (ASX:WBT) We spoke with Coby Hanoch, CEO of Weebit Nano (ASX:WBT), about the company’s…
QPM Energy (ASX: QPM) is taking full advantage of high electricity prices
QPM Energy (ASX: QPM) We spoke to David Wrench, CEO of QPM Energy (ASX: QPM), and…
Axel REE (ASX:AXL) is in a great position with rare earths set to make a comeback in 2025
Axel REE (ASX:AXL) We spoke to Dr. Fernando Tallarico, CEO of Axel REE (ASX:AXL), about the…
Vinyl Group (ASX:VNL) is reinventing the music industry
Vinyl Group (ASX:VNL) We talked with Josh Simons, CEO of Vinyl Group (ASX:VNL), about the growth…
Battery Age Minerals (ASX: BM8) could become a major supplier of Germanium: CEO interview.
Battery Age Minerals (ASX: BM8) We spoke with Nigel Broomham, CEO of Battery Age Minerals (ASX:…
The Calmer Company (ASX:CCO) is getting major traction with its Kava products
Calmer Company (ASX:CCO) We spoke with Dr. Anthony Noble, CEO of The Calmer Company (ASX:CCO), about…
Nyrada (ASX:NYR) is making solid progress going into 2025: Interview with CEO James Bonnar
Nyrada (ASX:NYR) We talked to James Bonnar, CEO of Nyrada (ASX: NYR), about the company’s remarkable…
BrainChip is set for a big 2025: Interview with CEO
BrainChip (ASX:BRN) We spoke to Sean Hehir, CEO of BrainChip (ASX:BRN), about commercial opportunities in the…
Highfield Resources’ (ASX:HFR) Muga Potash project is a company maker!
Highfield Resources (ASX:HFR) We spoke to Ignacio Salazar, CEO of Highfield Resources (ASX:HFR), about the recent…
Island Pharmaceuticals (ASX:ILA) is in Phase 2 with ILA-101
Island Pharmaceuticals (ASX:ILA) We spoke to Dr Paul MacLeman, Executive Chairman of Island Pharmaceuticals (ASX:ILA), about…
4DS Memory (ASX:4DS) is building momentum going into 2025
4DS Memory (ASX:4DS) We spoke with Peter Himes, CTO of 4DS Memory (ASX:4DS), about the company’s…
BluGlass (ASX:BLG): Interview with CEO Jim Haden
BluGlass (ASX:BLG) We spoke with BluGlass CEO Jim Haden, who was in Sydney for Semiconductor Australia…
Rhythm Biosciences (ASX: RHY): Interview with CEO David Atkins
Rhythm Biosciences (ASX:RHY) We spoke to Dr. David Atkins, CEO of Rhythm Biosciences (ASX: RHY), about…
AFT Pharmaceuticals (ASX:AFP) at the Pitt Street Research Life Sciences Conference 2024
AFT Pharmaceuticals (ASX:AFP) AFT Pharmaceuticals (ASX:AFP) CEO Dr. Harley Atkinson presented at the Pitt Street Research…